Empfehlung
12,2
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
54.3
7 neu, 2 erhöht, 1,7M $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | KAZIA THERAPEUTICS LTD |
|---|---|
| Ticker | KZIA |
| CIK | 0001075880 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | 48669g105 |
|---|---|
| ISIN | US48669G1058 |
| Typ | ADR |
| Titel | Kazia Therapeutics Ltd ADR |
Status
| Zuletzt geprüft | 2026-03-20 11:38:48.17571 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 300,000 | 0 | 300,000 | 2,067,000 | Neu | +100,0% | |
| Dauntless Investment Group, LLC | 118,139 | 0 | 118,139 | 851,782 | Neu | +100,0% | |
| Westside Investment Management, Inc. | 30,875 | 0 | 30,875 | 212,734 | Neu | +100,0% | |
| BARCLAYS PLC | 23,999 | 24,000 | -1 | 165,353 | Reduziert | 0,0% | |
| Rockefeller Capital Management L.P. | 10,700 | 10,700 | 0 | 73,723 | Unverändert | 0,0% | |
| Engineers Gate Manager LP | 10,388 | 0 | 10,388 | 71,573 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 1,565 | 591 | 974 | 10,779 | Aufgestockt | +164,8% | |
| MORGAN STANLEY | 1,000 | 200 | 800 | 6,890 | Aufgestockt | +400,0% | |
| GROUP ONE TRADING LLC | 800 | 0 | 800 | 4,960 | Neu | +100,0% | |
| GAMMA Investing LLC | 232 | 265 | -33 | 1,598 | Reduziert | -12,5% | |
| Arax Advisory Partners | 200 | 200 | 0 | 1,378 | Unverändert | 0,0% | |
| UBS Group AG | 193 | 3,543 | -3,350 | 1,330 | Reduziert | -94,6% | |
| SBI Securities Co., Ltd. | 100 | 0 | 100 | 627 | Neu | +100,0% | |
| MAI Capital Management | 52 | 52 | 0 | 375 | Unverändert | 0,0% | |
| OSAIC HOLDINGS, INC. | 10 | 10 | 0 | 68 | Unverändert | 0,0% | |
| FNY Investment Advisers, LLC | 7,500 | 0 | 7,500 | 51 | Neu | +100,0% | |
| Allworth Financial LP | 1 | 1 | 0 | 7 | Unverändert | 0,0% | |
| CITIGROUP INC | 1 | 639 | -638 | 7 | Reduziert | -99,8% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Velan Capital Investment Management LP | 300,000 | 2,067,000 | 79.12 |
| Westside Investment Management, Inc. | 30,875 | 212,734 | 8.14 |
| BARCLAYS PLC | 23,999 | 165,353 | 6.33 |
| Rockefeller Capital Management L.P. | 10,700 | 73,723 | 2.82 |
| Engineers Gate Manager LP | 10,388 | 71,573 | 2.74 |
| RHUMBLINE ADVISERS | 1,565 | 10,779 | 0.41 |
| MORGAN STANLEY | 1,000 | 6,890 | 0.26 |
| GAMMA Investing LLC | 232 | 1,598 | 0.06 |
| Arax Advisory Partners | 200 | 1,378 | 0.05 |
| UBS Group AG | 193 | 1,330 | 0.05 |
| OSAIC HOLDINGS, INC. | 10 | 68 | 0.00 |
| FNY Investment Advisers, LLC | 7,500 | 51 | 0.00 |
| CITIGROUP INC | 1 | 7 | 0.00 |
| Allworth Financial LP | 1 | 7 | 0.00 |